Get the Stockscreener App
0.3706
5.25%
0.0185
After Hours:
.35
-0.0206
-5.56%
Harvard Bioscience Inc Stock (HBIO) Forecast
The Harvard Bioscience Inc (HBIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.0332, representing a +988.29% increase from the current price of $0.3706. The highest analyst price target is $4.4496, and the lowest is $3.6169.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HBIO Price Target
Average 6.1981
(+1,572% Upside)
Is Harvard Bioscience Inc (HBIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.72 | Neutral |
| STOCH(9,6) | 14.08 | Buy |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0562 | Buy |
| ADX(14) | 36.12 | Buy |
| William %R | -78.79 | Neutral |
| CCI(14) | 18.28 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3316
Buy
|
0.342
Buy
|
| MA20 |
0.3582
Buy
|
0.3716
Sell
|
| MA50 |
0.5055
Sell
|
0.5818
Sell
|
| MA100 |
1.0922
Sell
|
1.0063
Sell
|
| MA200 |
1.8414
Sell
|
1.7286
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, HBIO could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on HBIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.72 indicates that HBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.08 indicates that HBIO is oversold. This indicates that HBIO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that HBIO is oversold. This suggests that HBIO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.12 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 18.28 indicates that HBIO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Harvard Bioscience Inc financial reports and earnings history, Harvard Bioscience Inc (HBIO) stock could reach $5.3154 by 2030, $11.90 by 2040 and $15.65 by 2050. See the projected annual prices until 2050 of the Harvard Bioscience Inc stock below:
- Harvard Bioscience Inc (HBIO) is expected to reach an average price of $8.8788 in 2035, with a high prediction of $8.9288 and a low estimate of $8.0079. This indicates an $2,296% rise from the last recorded price of $0.3706.
- Harvard Bioscience Inc (HBIO) stock is projected to chart a bullish course in 2040, with an average price target of $11.77, representing an $3,077% surge from its current level. The forecast ranges from a conservative $9.8379 to a sky-high $11.90.
- Our analysts predict Harvard Bioscience Inc (HBIO) to jump 2,642% by 2045, soaring from $9.9719 to an average price of $10.16, potentially reaching $10.92. While $9.9719 is the low estimate, the potential upside is significant.
- Harvard Bioscience Inc (HBIO) stock is expected to climb by 2050, reaching an average of $15.34, a $4,040% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.65 and $14.42, respectively, highlighting the market's uncertainty.
Harvard Bioscience Inc Stock (HBIO) Year by Year Forecast
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2025
Harvard Bioscience Inc Stock (HBIO) is expected to reach an average price of $4.4525 in 2025, with a high prediction of $5.9924 and a low estimate of $2.9125. This indicates an +1,101% rise from the last recorded price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $4.1296 | $3.6169 | $4.4496 | +1,014% |
| July, 2025 | $4.6031 | $4.115 | $4.7389 | +1,142% |
| August, 2025 | $5.0539 | $4.2558 | $5.3439 | +1,264% |
| September, 2025 | $5.7747 | $4.5185 | $5.8347 | +1,458% |
| October, 2025 | $4.7882 | $4.7282 | $5.9924 | +1,192% |
| November, 2025 | $4.6191 | $4.3464 | $4.9009 | +1,146% |
| December, 2025 | $5.0026 | $4.5418 | $5.1172 | +1,250% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2026
The predicted value for Harvard Bioscience Inc (HBIO) in 2026 is set at an average of $7.7384. Estimates vary from a peak of $10.49 to a trough of $4.9853, indicating an +1,988% surge from the present price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5034 | $4.9853 | $6.0307 | +1,385% |
| February, 2026 | $6.1092 | $5.3761 | $6.2242 | +1,548% |
| March, 2026 | $5.995 | $5.6969 | $6.305 | +1,518% |
| April, 2026 | $6.2686 | $5.7577 | $6.8759 | +1,591% |
| May, 2026 | $7.7794 | $5.544 | $8.7794 | +1,999% |
| June, 2026 | $8.2202 | $6.9148 | $8.3302 | +2,118% |
| July, 2026 | $8.7137 | $8.0929 | $9.501 | +2,251% |
| August, 2026 | $9.3545 | $8.4991 | $9.5645 | +2,424% |
| September, 2026 | $9.8981 | $8.7872 | $10.27 | +2,571% |
| October, 2026 | $9.6989 | $8.9435 | $10.19 | +2,517% |
| November, 2026 | $10.01 | $9.4566 | $10.49 | +2,601% |
| December, 2026 | $8.7532 | $8.6932 | $10.23 | +2,262% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Harvard Bioscience Inc (HBIO) is $7.5695, with a high forecast of $10.01 and a low forecast of $5.1295. This indicates an +1,942% increase from the last price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.724 | $8.1313 | $9.0759 | +2,254% |
| February, 2027 | $9.2248 | $8.6867 | $10.01 | +2,389% |
| March, 2027 | $8.6384 | $8.1531 | $9.2576 | +2,231% |
| April, 2027 | $7.8692 | $7.7192 | $9.1638 | +2,023% |
| May, 2027 | $7.74 | $7.2919 | $7.97 | +1,989% |
| June, 2027 | $7.2535 | $6.8281 | $8.0077 | +1,857% |
| July, 2027 | $8.0543 | $7.1962 | $8.3062 | +2,073% |
| August, 2027 | $7.6752 | $7.5552 | $8.3398 | +1,971% |
| September, 2027 | $5.6187 | $5.2234 | $7.7579 | +1,416% |
| October, 2027 | $5.1595 | $5.1295 | $6.3618 | +1,292% |
| November, 2027 | $5.7903 | $5.2622 | $5.8722 | +1,462% |
| December, 2027 | $5.1838 | $5.1338 | $5.863 | +1,299% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2028
In 2028, Harvard Bioscience Inc (HBIO) is projected to reach an average price of $6.1267, with a high projection of $8.3101 and a low estimate of $3.9433. This indicates an +1,553% rise from the last price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1347 | $5.0065 | $5.3893 | +1,285% |
| February, 2028 | $4.4855 | $4.1955 | $5.2174 | +1,110% |
| March, 2028 | $4.629 | $4.0809 | $4.7482 | +1,149% |
| April, 2028 | $4.3598 | $4.0444 | $4.7117 | +1,076% |
| May, 2028 | $4.6933 | $3.9433 | $4.9267 | +1,166% |
| June, 2028 | $4.8642 | $4.366 | $4.9742 | +1,213% |
| July, 2028 | $5.185 | $4.7769 | $5.285 | +1,299% |
| August, 2028 | $4.6685 | $4.4185 | $5.2077 | +1,160% |
| September, 2028 | $6.2693 | $4.4312 | $6.3993 | +1,592% |
| October, 2028 | $8.1801 | $6.20 | $8.3101 | +2,107% |
| November, 2028 | $7.7637 | $7.1155 | $8.2328 | +1,995% |
| December, 2028 | $7.5345 | $7.2591 | $8.2418 | +1,933% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2029
The 2029 price forecast for Harvard Bioscience Inc Stock (HBIO) is $6.5699 on average, with a high prediction of $7.9299 and a low estimate of $5.21. This represents an +1,673% increase from the previous price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.708 | $6.678 | $7.9299 | +1,710% |
| February, 2029 | $6.3788 | $6.0361 | $7.0107 | +1,621% |
| March, 2029 | $6.6296 | $6.1116 | $6.6996 | +1,689% |
| April, 2029 | $6.2304 | $6.095 | $6.7004 | +1,581% |
| May, 2029 | $6.104 | $5.904 | $6.6213 | +1,547% |
| June, 2029 | $6.5148 | $6.0167 | $6.8194 | +1,658% |
| July, 2029 | $7.4756 | $6.4175 | $7.6856 | +1,917% |
| August, 2029 | $6.5391 | $6.2837 | $7.5633 | +1,664% |
| September, 2029 | $6.5599 | $6.3499 | $7.0772 | +1,670% |
| October, 2029 | $6.3335 | $6.0035 | $6.7631 | +1,609% |
| November, 2029 | $5.8743 | $5.8643 | $6.8689 | +1,485% |
| December, 2029 | $5.21 | $5.21 | $6.1789 | +1,306% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2030
Harvard Bioscience Inc Stock (HBIO) is expected to reach an average price of $5.4137 in 2030, with a high forecast of $6.4788 and a low forecast of $4.3487. This signifies an +1,361% surge from the last price of $0.3706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.847 | $4.722 | $5.3154 | +1,208% |
| February, 2030 | $4.7187 | $4.3487 | $4.9725 | +1,173% |
| March, 2030 | $5.2203 | $4.5641 | $5.5195 | +1,309% |
| April, 2030 | $5.352 | $5.0857 | $5.6765 | +1,344% |
| May, 2030 | $5.979 | $5.1874 | $6.3382 | +1,513% |
| June, 2030 | $5.6706 | $5.5152 | $6.1044 | +1,430% |
| July, 2030 | $5.9677 | $5.3369 | $6.3327 | +1,510% |
| August, 2030 | $5.8193 | $5.7193 | $6.0885 | +1,470% |
| September, 2030 | $6.0909 | $5.7847 | $6.2109 | +1,544% |
| October, 2030 | $5.618 | $5.608 | $6.27 | +1,416% |
| November, 2030 | $5.2696 | $5.0896 | $6.4788 | +1,322% |
| December, 2030 | $5.1813 | $4.435 | $5.4704 | +1,298% |
1.71%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):